AbSci

IPO

Creating better biologics for patients, faster.

Public · Vancouver, United States · Founded 2011 · $379.5M raised

Employees
201–500
Founded
2011
Business Model
B2B
Website
absci.com
Total Funding
$379.5M
Last Round
$100.0M Growth EquityAug 2025
Rounds
6
Type
Public

About

Absci is a data-first generative AI drug creation company combining AI with scalable wet lab technologies to design better biologics. Their Integrated Drug Creation Platform uses deep learning and synthetic biology to go from AI-designed antibodies to wet lab-validated candidates in as little as six weeks, accelerating discovery against difficult-to-drug targets.

Summary

AbSci is an Artificial Intelligence company based in Vancouver, United States, founded in 2011. It has raised $379.5M in total across 6 rounds, most recently a $100.0M Growth Equity round in Aug 2025.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Growth EquityGrowth EquityAug 2025
$64.0M

Sign up to see all 7 rounds

Growth Equity — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AbSci on Indexed.vc
<a href="https://indexed.vc/companies/absci"><img src="https://indexed.vc/api/badge/company/absci" alt="AbSci on Indexed.vc" width="260" height="76" /></a>